First Time Loading...

Mesoblast Ltd
ASX:MSB

Watchlist Manager
Mesoblast Ltd Logo
Mesoblast Ltd
ASX:MSB
Watchlist
Price: 1.155 AUD 6.45% Market Closed
Updated: May 6, 2024

Mesoblast Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mesoblast Ltd
Cash from Operating Activities Peer Comparison

Comparables:
IMM
CSL
CUV
TLX
PYC

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Mesoblast Ltd
ASX:MSB
Cash from Operating Activities
-$59.1m
CAGR 3-Years
16%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Immutep Ltd
ASX:IMM
Cash from Operating Activities
-AU$35.4m
CAGR 3-Years
-34%
CAGR 5-Years
-29%
CAGR 10-Years
-10%
CSL Ltd
ASX:CSL
Cash from Operating Activities
$2.7B
CAGR 3-Years
-9%
CAGR 5-Years
11%
CAGR 10-Years
9%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Cash from Operating Activities
AU$42.3m
CAGR 3-Years
31%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Telix Pharmaceuticals Ltd
ASX:TLX
Cash from Operating Activities
AU$23.9m
CAGR 3-Years
130%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
Cash from Operating Activities
-AU$19.4m
CAGR 3-Years
-23%
CAGR 5-Years
-46%
CAGR 10-Years
-22%

See Also

What is Mesoblast Ltd's Cash from Operating Activities?
Cash from Operating Activities
-59.1m USD

Based on the financial report for Dec 31, 2023, Mesoblast Ltd's Cash from Operating Activities amounts to -59.1m USD.

What is Mesoblast Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-1%

Over the last year, the Cash from Operating Activities growth was 2%. The average annual Cash from Operating Activities growth rates for Mesoblast Ltd have been 16% over the past three years , -1% over the past five years .